These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8757587)

  • 1. Resistance to penicillin in Streptococcus pneumoniae.
    Wald ER
    J Pediatr; 1996 Jul; 129(1):178. PubMed ID: 8757587
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility.
    Hoberman A; Paradise JL; Block S; Burch DJ; Jacobs MR; Balanescu MI
    Pediatr Infect Dis J; 1996 Oct; 15(10):955-62. PubMed ID: 8895940
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation of COPD: amoxicillin + clavulanic acid in vitro activity vs S. pneumoniae, H. influenzae and M. catarrhalis.
    Beghi G; Legnani D; De Bartolo A; Pagani N; Lusco G
    J Chemother; 1995 Nov; 7 Suppl 4():61-2. PubMed ID: 8904109
    [No Abstract]   [Full Text] [Related]  

  • 5. [The postantibiotic effect of amoxicillin/clavulanic acid on Streptococcus pneumoniae strains of different serotypes and penicillin sensitivity].
    García Y; Gómez MJ; Ramos MC; Gómez-Lus ML; Prieto J
    Rev Esp Quimioter; 1998 Jun; 11(2):157-60. PubMed ID: 9795302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin.
    Corbel MJ; Ibrahim ME; Gill KP
    Vet Rec; 1984 Nov; 115(18):465. PubMed ID: 6568786
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
    Ruczkowska J; Dolna I
    Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance to amoxicillin/clavulanate in Escherichia coli.
    Colaert J
    Acta Clin Belg; 1992; 47(5):353-4. PubMed ID: 1334324
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance to amoxicillin/clavulanate in Escherichia coli.
    Glupczynski Y; Mac Gillavry G; Yourassowsky E
    Acta Clin Belg; 1992; 47(5):354-5. PubMed ID: 1334325
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH
    Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain.
    Isla A; Trocóniz IF; Canut A; Labora A; Martín-Herrero JE; Pedraz JL; Gascón AR
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):167-73. PubMed ID: 21334779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic management of acute otitis media. New recommendations].
    Longuet P
    Presse Med; 2000 Dec; 29(37):2049-50. PubMed ID: 11155733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.
    Easton J; Noble S; Perry CM
    Drugs; 2003; 63(3):311-40. PubMed ID: 12534334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation.
    Sevillano D; Aguilar L; Alou L; Giménez MJ; González N; Echeverría O; Torrico M; Valdes L; Coronel P; Prieto J
    Chemotherapy; 2008; 54(2):84-90. PubMed ID: 18303256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
    File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
    Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Lebanon.
    Uwaydah M; Jradeh M; Shihab Z
    J Antimicrob Chemother; 1996 Aug; 38(2):283-6. PubMed ID: 8877543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vitro activities of co-amoxiclav and other oral antibiotics against Streptococcus pneumoniae isolates exhibiting intermediate susceptibility to penicillin.
    Washington JA; Felmingham D
    J Antimicrob Chemother; 1998 Sep; 42(3):405-6. PubMed ID: 9786488
    [No Abstract]   [Full Text] [Related]  

  • 20. [A clinicobacteriologic study on clavulanic acid/amoxicillin in pediatric acute otitis media].
    Sugita R; Harada S; Deguchi K; Fujimaki Y; Naito M; Komatsu N; Nomura T; Okano K; Tanaka M; Shimizu K; Watanabe H; Kimura S; Yoshida Y; Senba T; Uchida T
    Jpn J Antibiot; 1999 Oct; 52(10):595-612. PubMed ID: 10638456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.